Background Accurate differentiation between periprosthetic joint infection (PJI) and aseptic loosening (AL) is essential for appropriate surgical planning and optimal postoperative outcomes. Although neutrophil infiltration remains the standard histological marker for diagnosing PJI, it has recognized limitations. Mast cells, which play a role in chronic inflammatory responses, may serve as a complementary biomarker. This study evaluated the combined diagnostic utility of Giemsa-stained mast cell density and neutrophil counts in periprosthetic tissue to distinguish PJI from AL. Methods This single-center retrospective cohort study included patients who underwent revision arthroplasty between January 2022 and September 2025. PJI was defined according to the 2018 International Consensus Meeting criteria, whereas AL was diagnosed based on negative microbiological cultures and radiographic evidence of loosening. Periprosthetic tissue samples were stained with H 0.237 mm² per field). Results A total of 146 revision cases were analyzed, including 48 PJI and 98 AL cases. Median neutrophil counts were significantly higher in the PJI group than in the AL group (26.5 vs. 1.0 cells/HPF; p < 0.001). Conversely, median mast cell density was significantly higher in AL (11.0 vs. 3.5 cells/HPF; p < 0.001). A neutrophil threshold of ≥5 cells/HPF demonstrated 93.8% sensitivity and 91.8% specificity for diagnosing PJI (area under the curve (AUC) = 0.97). A mast cell cutoff of ≥7 cells/HPF showed 86.7% sensitivity and 85.4% specificity for diagnosing AL (AUC = 0.91). The combined sequential algorithm achieved an overall diagnostic accuracy of 93.2%. Conclusions Giemsa-stained mast cell density is a novel, cost-effective histological marker elevated in AL. When combined with neutrophil counts, it improves diagnostic accuracy and may serve as a practical adjunct in the routine pathological evaluation of revision arthroplasty specimens.
Pathan et al. (Sat,) studied this question.